PASITHEA THERAPEUTICS CORP. Cash Provided by (Used in) Operating Activities, Discontinued Operations
PASITHEA THERAPEUTICS CORP. (KTTA) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2025-03-24
- PASITHEA THERAPEUTICS CORP. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-12-31 was -$16.89K.
- PASITHEA THERAPEUTICS CORP. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-09-30 was -$11.25K.
- PASITHEA THERAPEUTICS CORP. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-06-30 was -$399.69K, a 3836.11% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-03-31 was -$183.44K.
- PASITHEA THERAPEUTICS CORP. cash provided by (used in) operating activities, discontinued operations for fiscal 2024 was $0.00.
- PASITHEA THERAPEUTICS CORP. cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was -$611.28K.
- PASITHEA THERAPEUTICS CORP. cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was -$1.80M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-24 | |||
| 2023-12-31 | -$16.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$28.14K derived: sum of 2 quarters · filed 2025-03-24 | -$427.83K derived: sum of 3 quarters · filed 2025-03-24 | -$611.28K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$11.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$410.94K derived: sum of 2 quarters · filed 2024-11-13 | -$594.38K 10-Q · filed 2024-11-13 | -$1.36M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$399.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$583.13K 10-Q · filed 2024-08-13 | -$1.35M derived: sum of 3 quarters · filed 2024-08-13 | -$1.98M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$183.44K 10-Q · filed 2024-05-14 | -$953.12K derived: sum of 2 quarters · filed 2024-05-14 | -$1.58M derived: sum of 3 quarters · filed 2024-05-14 | -$1.57M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$769.68K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$1.40M derived: sum of 2 quarters · filed 2024-03-29 | -$1.39M derived: sum of 3 quarters · filed 2024-03-29 | -$1.80M 10-K · filed 2024-03-29 |
| 2022-09-30 | -$626.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$615.66K derived: sum of 2 quarters · filed 2023-11-13 | -$1.03M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $10.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$400.55K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | -$411.25K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |